Massimo Valerio

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


145 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
Sous presse
 
WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M. Progres en urologie. Peer-reviewed.
[DOI][Pmid][serval:BIB_8CFD71B1DDEF]
2024
 
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy.
Martini A., Wever L., Soeterik TFW, Rakauskas A., Fankhauser C.D., Grogg J.B., Checcucci E., Amparore D., Haiquel L., Rodriguez-Sanchez L. et al., 2024/09. Prostate cancer and prostatic diseases, 27 (3) pp. 520-524. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00422DF903AC]
 
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy.
Pavlovic B., Bräutigam K., Dartiguenave F., Martel P., Rakauskas A., Cesson V., Veit M., Oechslin P., Gu A., Hermanns T. et al., 2024/08/05. Scientific reports, 14 (1) p. 18148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E999C7BB15AD]
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection.
Maurer J., Eugster P.J., Collins K., Vocat C., Oke J., Nicholson B., Rakauskas A., Grouzmann E., Valerio M., 2024/08. European urology open science, 66 pp. 12-15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_803CC99B0FD9]
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study.
Cloître M., Benkhaled S., Boughdad S., Schaefer N., Prior J.O., Zeverino M., Berthold D., Tawadros T., Meuwly J.Y., Martel P. et al., 2024/05/31. Cancers, 16 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F69D11E34A2A]
 
The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
Sorce G., Stabile A., Pellegrino F., Mazzone E., Mattei A., Afferi L., Serni S., Minervini A., Roumiguiè M., Malavaud B. et al., 2024/04/22. World journal of urology, 42 (1) p. 248. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47A3EF869A92]
 
Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT.
Ditonno F., Franco A., Manfredi C., Veccia A., Valerio M., Bukavina L., Zukowski L.B., Vourganti S., Stenzl A., Andriole G.L. et al., 2024/03. Prostate cancer and prostatic diseases, 27 (1) pp. 29-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D894860FC2B8]
2023
 
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A., Touzani A., Mazzone E., Roumiguié M., Marra G., Valerio M., Beauval J.B., Campi R., Minervini A., van den Berg RCN et al., 2023/12. Prostate cancer and prostatic diseases, 26 (4) p. 806. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ADBC7CB5E0FE]
 
Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Deivasigamani S., Kotamarti S., Rastinehad A.R., Salas R.S., de la Rosette JJMCH, Lepor H., Pinto P., Ahmed H.U., Gill I., Klotz L. et al., 2023/12. European urology, 84 (6) pp. 547-560. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_85999C21315A]
 
Chirurgie robot-assistée en urologie fonctionnelle et reconstructive [Robotic-assisted laparoscopic surgeries in functional and reconstructive urology]
Germanou A., Perrin A., Grilo N., Valerio M., Windisch O., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2243-2246. Peer-reviewed.
[URN][Pmid][serval:BIB_543FAF172D51]
 
Les décisions de politique de santé n’ont pas toujours l’effet escompté. L’exemple de l’urologie.
Valerio M., Roth B., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2231-2232. Peer-reviewed.
[URN][Pmid][serval:BIB_73EDFE358858]
 
Les nombreux impacts urologiques du tabagisme [The many urological consequences of smoking]
Grégoris A., Valerio M., Abboud A.E., Grobet-Jeandin E., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2234-2238. Peer-reviewed.
[URN][Pmid][serval:BIB_51CCC7120E01]
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol.
Schaer S., Rakauskas A., Dagher J., La Rosa S., Pensa J., Brisbane W., Marks L., Kinnaird A., Abouassaly R., Klein E. et al., 2023/11. World journal of urology, 41 (11) pp. 3325-3331. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEAD408FE4CC]
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Zattoni F., Marra G., Martini A., Kasivisvanathan V., Grummet J., Harkin T., Ploussard G., Olivier J., Chiu P.K., Valerio M. et al., 2023/07. European urology focus, 9 (4) pp. 621-628. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_45DB65153FBF]
 
Reply by Authors.
Martini A., Wever L., Soeterik TFW, Rakauskas A., Fankhauser C.D., Grogg J.B., Checcucci E., Amparore D., Haiquel L., Rodriguez-Sanchez L. et al., 2023/07. The Journal of urology, 210 (1) p. 127. Peer-reviewed.
[DOI][Pmid][serval:BIB_9126155102A3]
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
Martini A., Wever L., Soeterik TFW, Rakauskas A., Fankhauser C.D., Grogg J.B., Checcucci E., Amparore D., Haiquel L., Rodriguez-Sanchez L. et al., 2023/07. The Journal of urology, 210 (1) pp. 117-127. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_96BC64851E19]
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
Ahmed R., Lozano L.E., Anastasio A., Lofek S., Mastelic-Gavillet B., Navarro Rodrigo B., Nguyen S., Dartiguenave F., Rodrigues-Dias S.C., Cesson V. et al., 2023/06/08. Cancers, 15 (12) p. 3114. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F3B91EA43E2]
 
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.
Sacco M., Gandaglia G., Aas K., Ceci F., Chiu P., Fankhauser C.D., Fournier G., Heiddeger I., Kasivisvanathan V., Kesch C. et al., 2023/06. Clinical genitourinary cancer, 21 (3) pp. 416.e1-416.e10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34E94756C7AD]
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.
Mattana F., Muraglia L., Rajwa P., Zattoni F., Marra G., Chiu PKF, Heidegger I., Kasivisvanathan V., Kesch C.V., Olivier J. et al., 2023/04. European urology oncology, 6 (2) pp. 128-136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31C7EBBA2C16]
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M., Valerio M., Mampuya A., Rakauskas A., Berthold D., Tawadros T., Meuwly J.Y., Heym L., Duclos F., Vallet V. et al., 2023/04/01. The British journal of radiology, 96 (1145) p. 20220803. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB3AC2C2AFDE]
 
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.
Rajwa P., Yanagisawa T., Heidegger I., Zattoni F., Marra G., Soeterik TFW, van den Bergh RCN, Valerio M., Ceci F., Kesch C.V. et al., 2023/03. Prostate cancer and prostatic diseases, 26 (1) pp. 170-179. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24C5F28F8850]
 
Screening of visceral metastasis in castration-resistant prostate cancer: a cornerstone in personalized patient's care.
Grobet-Jeandin E., Valerio M., 2023/03. Prostate cancer and prostatic diseases, 26 (1) pp. 3-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FFA752A7F7CA]
 
Single Seminal Vesicle Metastasis From Dorsal Melanoma Detected by 18 F-FDG PET/CT and Confirmed by Biopsy.
Testart Dardel N., Isenborghs E., Valerio M., Michielin O., Schaefer N., 2023/03/01. Clinical nuclear medicine, 48 (3) pp. e151-e152. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E552B0535E6B]
 
An Algorithm to Personalize Nerve Sparing in Men With Unilateral High-risk Prostate Cancer. Reply.
Martini A., Valerio M., 2023/02. The Journal of urology, 209 (2) p. 325. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BA716A2CF50]
Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A., Peters M., Martel P., van Rossum PSN, La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2023. PloS one, 18 (1) pp. e0280262. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F7AFB48B00B]
Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
Marra G., Calleris G., Massari E., Vissio E., Molinaro L., Cassoni P., D'Agate D., Oderda M., Valerio M., Raskin Y. et al., 2023/01. European urology open science, 47 pp. 110-118. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A8F9C9C6814A]
2022
 
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines.
Stangl-Kremser J., Lambertini L., Di Maida F., Martinez-Fundichely A., Ferro M., Pradere B., Soria F., Albisinni S., Wu Z., Del Giudice F. et al., 2022/11. European urology focus, 8 (6) pp. 1622-1626. Peer-reviewed.
[DOI][Pmid][serval:BIB_DCCC7EAF71A1]
 
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society.
Marra G., Laguna M.P., Walz J., Pavlovich C.P., Bianco F., Gregg J., Lebastchi A.H., Lepor H., Macek P., Rais-Bahrami S. et al., 2022/10. Minerva urology and nephrology, 74 (5) pp. 581-589. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D3E83875F4A4]
 
The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F., Marra G., Kasivisvanathan V., Grummet J., Nandurkar R., Ploussard G., Olivier J., Chiu P.K., Valerio M., Gontero P. et al., 2022/10. The Journal of urology, 208 (4) pp. 830-837. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8480C6BC4077]
ERAS® protocol improves survival after radical cystectomy: A single-center cohort study.
Crettenand F., M'Baya O., Grilo N., Valerio M., Dartiguenave F., Cerantola Y., Roth B., Rouvé J.D., Blanc C., Lucca I., 2022/09/02. Medicine, 101 (35) pp. e30258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DCB34BAF3D6A]
 
Re: Multiparametric Ultrasound Versus Multiparametric MRI To Diagnose Prostate Cancer (CADMUS): A Prospective, Multicentre, Paired-cohort, Confirmatory Study.
Rakauskas A., Valerio M., Roth B., 2022/08. European urology, 82 (2) pp. 239-240. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_185E142D90D8]
 
The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2022/06. Progres en urologie, 32 (6S1) pp. 6S26-6S32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB1BFE80ABF7]
 
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Reddy D., Peters M., Shah T.T., van Son M., Tanaka M.B., Huber P.M., Lomas D., Rakauskas A., Miah S., Eldred-Evans D. et al., 2022/04. European urology, 81 (4) pp. 407-413. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_592DC74F8BA4]
 
Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A., Touzani A., Mazzone E., Roumiguié M., Marra G., Valerio M., Beauval J.B., Campi R., Minervini A., van den Berg RCN et al., 2022/04. Prostate cancer and prostatic diseases, 25 (4) pp. 794-796. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6106ADB0A5F5]
Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer.
Alijaj N., Pavlovic B., Martel P., Rakauskas A., Cesson V., Saba K., Hermanns T., Oechslin P., Veit M., Provenzano M. et al., 2022/02/23. Cancers, 14 (5) p. 1135. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C3E7756D66D6]
 
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.
Martini A., Soeterik TFW, Haverdings H., Rahota R.G., Checcucci E., De Cillis S., Hermanns T., Fankhauser C.D., Afferi L., Moschini M. et al., 2022/02. The Journal of urology, 207 (2) pp. 350-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B656081004E1]
 
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
Mazzone E., Gandaglia G., Ploussard G., Marra G., Valerio M., Campi R., Mari A., Minervini A., Serni S., Moschini M. et al., 2022/02. European urology, 81 (2) pp. 193-203. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2AAF3078670]
 
An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?
Hopstaken J.S., Bomers JGR, Sedelaar MJP, Valerio M., Fütterer J.J., Rovers M.M., 2022/01. European urology, 81 (1) pp. 5-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_308D753969EA]
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review.
Heidegger I., Kesch C., Kretschmer A., Tsaur I., Ceci F., Valerio M., Tilki D., Marra G., Preisser F., Fankhauser C.D. et al., 2022. Therapeutic advances in medical oncology, 14 p. 17588359221081922. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FEAACAC3A245]
 
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.
Laine C., Gandaglia G., Valerio M., Heidegger I., Tsaur I., Olivier J., Ceci F., van den Bergh RCN, Kretschmer A., Thibault C. et al., 2022/01/01. Current opinion in urology, 32 (1) pp. 69-84. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B4E3EF406EC]
The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol.
Marra G., Shah T.T., D'Agate D., Marquis A., Calleris G., Lunelli L., Filippini C., Oderda M., Gatti M., Valerio M. et al., 2022. Frontiers in surgery, 9 p. 900528. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_861CF12CB630]
2021
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives.
Kretschmer A., van den Bergh RCN, Martini A., Marra G., Valerio M., Tsaur I., Heidegger I., Kasivisvanathan V., Kesch C., Preisser F. et al., 2021/12/29. Cancers, 14 (1) p. 147. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F08AFBD56FCD]
Infirmière clinicienne de centre du cancer : l’expérience du Centre de la prostate du CHUV [Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Codeluppi C., Ninane F., Jolliet L., Glemarec P., Orcurto A., Rakauskas A., Tawadros T., Bosshard P., Eicher M., Herrera F. et al., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2082-2085. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B3EF72B4777A]
Les biomarqueurs émergents du cancer de la prostate [Emerging biomarkers of prostate cancer]
Rakauskas A., Martel P., Roth B., Valerio M., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2078-2081. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1971E9F929B2]
Traitement de l’hyperplasie bénigne de la prostate - Alternatives chirurgicales à la résection transurétrale de la prostate [Benign prostatic hyperplasia treatment: Surgical alternatives to transurethral resection of the prostate]
Stritt K., Bosshard P., Roth B., Valerio M., Rakauskas A., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2074-2076. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_208F61BDA3DE]
 
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.
Kretschmer A., Mazzone E., Barletta F., Leni R., Heidegger I., Tsaur I., van den Bergh RCN, Valerio M., Marra G., Kasivisvanathan V. et al., 2021/11. European urology focus, 7 (6) pp. 1247-1253. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28F50CBA6159]
 
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Heidegger I., Necchi A., Pircher A., Tsaur I., Marra G., Kasivisvanathan V., Kretschmer A., Mathieu R., Ceci F., van den Bergh RCN et al., 2021/10. European urology oncology, 4 (5) pp. 745-754. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47600037FE32]
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.
Rakauskas A., Tawadros T., Lucca I., Herrera F., Bourhis J., Burruni R., Gomes M.N., Codeluppi C., Jolliet L., La Rosa S. et al., 2021/07. Investigative and clinical urology, 62 (4) pp. 416-422. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_11DA8B398364]
 
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
Surcel C., Mirvald C., Tsaur I., Borgmann H., Heidegger I., Labanaris A.P., Sinescu I., Tilki D., Ploussard G., Briganti A. et al., 2021/07. World journal of urology, 39 (7) pp. 2483-2490. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8951C7A2C761]
 
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Kretschmer A., Ploussard G., Heidegger I., Tsaur I., Borgmann H., Surcel C., Mathieu R., de Visschere P., Valerio M., van den Bergh RCN et al., 2021/07. European urology focus, 7 (4) pp. 742-751. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4BC5114D813]
 
3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.
Amparore D., Fiori C., Valerio M., Schulman C., Giannakis I., De Cillis S., Kadner G., Porpiglia F., 2021/06. Prostate cancer and prostatic diseases, 24 (2) pp. 349-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE8494163BAA]
 
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Shah T.T., Reddy D., Peters M., Ball D., Kim N.H., Gomez E.G., Miah S., Evans D.E., Guillaumier S., van Rossum PSN et al., 2021/06. Prostate cancer and prostatic diseases, 24 (2) pp. 567-574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2421F39C0207]
 
The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
Perrin A., Venderink W., Patak M.A., Möckel C., Fehr J.L., Jichlinski P., Porcellini B., Lucca I., Futterer J., Valerio M., 2021/05. Urologic oncology, 39 (5) pp. 297.e9-297.e16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75768B5492B4]
Endoscopic treatment of spinal arachnoid cysts.
Papadimitiou K., Cossu G., Maduri R., Valerio M., Vamadevan S., Daniel R.T., Messerer M., 2021/04. Heliyon, 7 (4) pp. e06736. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_55494A53313A]
 
Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer.
Shah T.T., Peters M., Miah S., Eldred-Evans D., Yap T., Hosking-Jervis F., Dudderidge T., Hindley R.G., McCracken S., Greene D. et al., 2021/03. European urology focus, 7 (2) pp. 301-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A20DFBCC55B]
Focal Therapy for Prostate Cancer: Complications and Their Treatment.
Rakauskas A., Marra G., Heidegger I., Kasivisvanathan V., Kretschmer A., Zattoni F., Preisser F., Tilki D., Tsaur I., van den Bergh R. et al., 2021. Frontiers in surgery, 8 p. 696242. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_33DF868574CF]
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
Zattoni F., Heidegger I., Kasivisvanathan V., Kretschmer A., Marra G., Magli A., Preisser F., Tilki D., Tsaur I., Valerio M. et al., 2021. Frontiers in surgery, 8 p. 691473. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6ADAA0729F8F]
Radical Prostatectomy: Sequelae in the Course of Time.
Kesch C., Heidegger I., Kasivisvanathan V., Kretschmer A., Marra G., Preisser F., Tilki D., Tsaur I., Valerio M., van den Bergh RCN et al., 2021. Frontiers in surgery, 8 p. 684088. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD54FA7598E0]
2020
 
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G., Ploussard G., Valerio M., Marra G., Moschini M., Martini A., Roumiguié M., Fossati N., Stabile A., Beauval J.B. et al., 2020/12. European urology oncology, 3 (6) pp. 739-747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_71F1041E429D]
 
Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
Kadner G., Valerio M., Giannakis I., Manit A., Lumen N., Ho BSH, Alonso S., Schulman C., Barber N., Amparore D. et al., 2020/12. World journal of urology, 38 (12) pp. 3235-3244. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5FBFE201D43E]
 
The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F., Martins M., Regusci S., Jichlinski P., Meuwly J.Y., Lucca I., Valerio M., 2020/11. Urologic oncology, 38 (11) pp. 846.e1-846.e7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_913CBD0A1EF2]
 
Editorial Comment.
Valerio M., 2020/10. The Journal of urology, 204 (4) p. 747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B637FD90C1A3]
 
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
Marra G., Valerio M., Heidegger I., Tsaur I., Mathieu R., Ceci F., Ploussard G., van den Bergh RCN, Kretschmer A., Thibault C. et al., 2020/10. European urology oncology, 3 (5) pp. 565-581. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B7F64D3CED0]
 
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Gandaglia G., Martini A., Ploussard G., Fossati N., Stabile A., De Visschere P., Borgmann H., Heidegger I., Steinkohl F., Kretschmer A. et al., 2020/08. European urology, 78 (2) pp. 138-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4B472016C136]
 
Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.02.009.
van den Bergh RCN, Valerio M., Tilki D., Gandaglia G., EAU-YAU Prostate Cancer Working Party, 2020/08. European urology, 78 (2) pp. e67-e68. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D713775F1FDE]
 
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G., Ploussard G., Valerio M., Mattei A., Fiori C., Roumiguié M., Fossati N., Stabile A., Beauval J.B., Malavaud B. et al., 2020/06. European urology, 77 (6) pp. 733-741. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17E44A5AE5D7]
 
Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27-30: Salvage Robotic Radical Prostatectomy for Recurrent Prostate Cancer After Focal Therapy.
Marra G., Van Velthoven R., Valerio M., 2020/04. European urology, 77 (4) pp. e103-e104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_498095BEB288]
 
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L., Lucca I., Cesson V., Valerio M., Cerantola Y., Burruni R., Fritschi U., Gharbi D., Bobst M., Legris A.S. et al., 2020/03/15. European urology focus, 6 (2) pp. 280-283. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_278D1CCE5A4E]
2019
 
Reduction and follow-up of hospital discharge letter delay using Little's law.
Burruni R., Cuany B., Valerio M., Jichlinski P., Kulik G., 2019/12/31. International journal for quality in health care, 31 (10) pp. 787-792. Peer-reviewed.
[DOI][Pmid][serval:BIB_F7F6F212624D]
 
Hereditary prostate cancer - Primetime for genetic testing?
Heidegger I., Tsaur I., Borgmann H., Surcel C., Kretschmer A., Mathieu R., Visschere P., Valerio M., van den Bergh RCN, Ost P. et al., 2019/12. Cancer treatment reviews, 81 p. 101927. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80416CC7D80B]
Imaging modalities in synchronous oligometastatic prostate cancer.
Futterer J.J., Surcel C., van den Bergh R., Borgmann H., Briganti A., Gandaglia G., Kretschmer A., Ost P., Sooriakumaran P., Tilki D. et al., 2019/12. World journal of urology, 37 (12) pp. 2573-2583. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0AE3D10E4255]
Prise en charge de cancers urologiques chez la population âgée : quels enjeux ? [Management of urologic cancers in elderly people : which implications ?]
Schaer S., Valerio M., Jichlinski P., Lucca I., 2019/11/27. Revue medicale suisse, 15 (673) pp. 2195-2197. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EAE3635D7B71]
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cells.
Mastelic-Gavillet B., Navarro Rodrigo B., Décombaz L., Wang H., Ercolano G., Ahmed R., Lozano L.E., Ianaro A., Derré L., Valerio M. et al., 2019/10/10. Journal for immunotherapy of cancer, 7 (1) p. 257. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC3C085DEA43]
 
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
Ploussard G., Gandaglia G., Borgmann H., de Visschere P., Heidegger I., Kretschmer A., Mathieu R., Surcel C., Tilki D., Tsaur I. et al., 2019/10. European urology, 76 (4) pp. 493-504. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_95DE57188670]
 
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.
Kasivisvanathan V., Stabile A., Neves J.B., Giganti F., Valerio M., Shanmugabavan Y., Clement K.D., Sarkar D., Philippou Y., Thurtle D. et al., 2019/09. European urology, 76 (3) pp. 284-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8182888D4478]
 
Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G., Valerio M., Emberton M., Heidenreich A., Crook J.M., Bossi A., Pisters L.L., 2019/09. European urology oncology, 2 (5) pp. 526-538. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1014465520F4]
 
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
Shah T.T., Peters M., Eldred-Evans D., Miah S., Yap T., Faure-Walker N.A., Hosking-Jervis F., Thomas B., Dudderidge T., Hindley R.G. et al., 2019/07. European urology, 76 (1) pp. 98-105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BEEE92989FB]
 
Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F., Fiori C., Amparore D., Kadner G., Manit A., Valerio M., Nicolaas L., Ho BSH, Alonso S., Schulman C. et al., 2019/06. BJU international, 123 (6) pp. 1061-1069. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6E33B53038F]
 
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Tsaur I., Heidegger I., Kretschmer A., Borgmann H., Gandaglia G., Briganti A., de Visschere P., Mathieu R., Valerio M., van den Bergh R. et al., 2019/05. Cancer treatment reviews, 75 pp. 20-26. Peer-reviewed.
[DOI][Pmid][serval:BIB_EB165AD616DE]
 
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G., Ploussard G., Valerio M., Mattei A., Fiori C., Fossati N., Stabile A., Beauval J.B., Malavaud B., Roumiguié M. et al., 2019/03. European urology, 75 (3) pp. 506-514. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_592DD33BF83B]
 
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
van den Bergh R., Gandaglia G., Tilki D., Borgmann H., Ost P., Surcel C., Valerio M., Sooriakumaran P., Salomon L., Briganti A. et al., 2019/03. European urology focus, 5 (2) pp. 171-178. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30F7D20D669D]
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A5A6B3310C5]
 
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
Marra G., Ploussard G., Futterer J., Valerio M., EAU-YAU Prostate Cancer Working Party, 2019/02. World journal of urology, 37 (2) pp. 277-287. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_67067727E208]
 
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Ploussard G., Borgmann H., Briganti A., de Visschere P., Fütterer J.J., Gandaglia G., Heidegger I., Kretschmer A., Mathieu R., Ost P. et al., 2019/02. World journal of urology, 37 (2) pp. 243-251. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56C9ABE1591F]
 
Re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
Valerio M., Emberton M., Ahmed H.U., 2019/02. European urology, 75 (2) pp. e21-e22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21CF45CEB63A]
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
Bohner P., Chevalier M.F., Cesson V., Rodrigues-Dias S.C., Dartiguenave F., Burruni R., Tawadros T., Valerio M., Lucca I., Nardelli-Haefliger D. et al., 2019. Frontiers in immunology, 10 p. 622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BC4F69D1158]
2018
 
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey.
Marra G., Ploussard G., Ost P., De Visschere PJL, Briganti A., Gandaglia G., Tilki D., Surcel C.I., Tsaur I., Van Den Bergh RCN et al., 2018/12. Urologic oncology, 36 (12) pp. 529.e11-529.e22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF67FC7B567A]
 
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.
Gandaglia G., van den Bergh RCN, Tilki D., Fossati N., Ost P., Surcel C.I., Sooriakumaran P., Tsaur I., Valerio M., Kretschmer A. et al., 2018/11. BJU international, 122 (5) pp. 823-830. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B76219102FFE]
 
Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology.
van den Bergh RCN, Ost P., Surcel C., Valerio M., Fütterer J.J., Gandaglia G., Sooriakumaran P., Tilki D., Tsaur I., Ploussard G. et al., 2018/09. World journal of urology, 36 (9) pp. 1489-1494. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C124C2EBA90D]
 
New technologies and techniques for prostate cancer focal therapy.
Linares-Espinós E., Carneiro A., Martínez-Salamanca J.I., Bianco F., Castro-Alfaro A., Cathelineau X., Valerio M., Sanchez-Salas R., 2018/06. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 70 (3) pp. 252-263. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84639820903A]
 
Re: Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy: I. Nunes-Silva, E. et al.
Shah T.T., Valerio M., Ahmed H.U., 2018/06. The Journal of urology, 199 (6) pp. 1634-1635. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A02C2F1F6666]
 
Multiparametric prostate MRI: technical conduct, standardized report and clinical use.
Manfredi M., Mele F., Garrou D., Walz J., Fütterer J.J., Russo F., Vassallo L., Villers A., Emberton M., Valerio M., 2018/02. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 70 (1) pp. 9-21. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D4EE9574E72]
2017
An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.
Campelo S., Valerio M., Ahmed H.U., Hu Y., Arena S.L., Neal R.E., Emberton M., Arena C.B., 2017/12. APL bioengineering, 1 (1) p. 016101. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BDA6220A2F72]
Ablation du cancer primaire dans les néoplasies urologiques oligométastatiques : évidence ou vœux pieux ? [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?]
Valerio M., Cerantola Y., Lucca I., Berthold D., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2083-2086. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3B730D56DD60]
 
Focal therapy as primary treatment for localized prostate cancer: definition, needs and future.
Ouzzane A., Betrouni N., Valerio M., Rastinehad A., Colin P., Ploussard G., 2017/04. Future oncology, 13 (8) pp. 727-741. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BAD163CF6068]
 
Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M., Shah T.T., Shah P., Mccartan N., Emberton M., Arya M., Ahmed H.U., 2017/04. Urologic oncology, 35 (4) pp. 150.e1-150.e7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_357A07045CE9]
 
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M., Dickinson L., Ali A., Ramachadran N., Donaldson I., Mccartan N., Freeman A., Ahmed H.U., Emberton M., 2017/03. The Journal of urology, 197 (3 Pt 1) pp. 647-654. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93F05364D7E4]
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E871163C3ED]
 
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M., Cerantola Y., Eggener S.E., Lepor H., Polascik T.J., Villers A., Emberton M., 2017/01. European urology, 71 (1) pp. 17-34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C48D18F9D56D]
2016
 
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey.
Bultijnck R., Surcel C., Ploussard G., Briganti A., De Visschere P., Fütterer J., Ghadjar P., Giannarini G., Isbarn H., Massard C. et al., 2016/12. European urology focus, 2 (5) pp. 514-521. Peer-reviewed.
[DOI][Pmid][serval:BIB_6764FCF6F372]
 
Médicaments usuels en médecine de premier recours et cancer de la prostate : quelle relation ? [Common medications and prostate cancer : what is the association ?]
Rakauskas A., Grilo N., M'Baya O., Jichlinski P., Valerio M., Berthold D., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2068-2071. Peer-reviewed.
[Pmid][serval:BIB_A37D39541A4B]
 
Prise en charge des traumatismes urogénitaux [Management of genitourinary trauma]
Perrin A., Grilo N., Meuwly J.Y., Jichlinski P., Valerio M., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2072-2076. Peer-reviewed.
[Pmid][serval:BIB_578D4A48280E]
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.
El-Shater Bosaily A., Valerio M., Hu Y., Freeman A., Jameson C., Brown L., Kaplan R., Hindley R.G., Barratt D., Emberton M. et al., 2016/09. Prostate cancer and prostatic diseases, 19 (3) pp. 258-263. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_68039086F327]
 
Cambiando la vía de manejo del cáncer de próstata: ¿Por qué la Terapia Focal es un paso adelante? [Changing the prostate cancer management pathway: why Focal Therapy is a step forward]
Marra G., Gontero P., Valerio M., 2016/07. Archivos espanoles de urologia, 69 (6) pp. 271-280. Peer-reviewed.
[Pmid][serval:BIB_C0C94E3CD803]
 
The role of minimally invasive surgery on enhanced recovery after nephrectomy
M'Baya Olivier, Grilo Nuno, Valerio Massimo, Dartiguenave Florence, Puricel Serban, Blanc Catherine, Jichlinski Patrice, Cerantola Yannick, 2016/04. pp. e52 dans Clinical Nutrition ESPEN.
[DOI][serval:BIB_2256BCEFBB19]
 
Addressing overtreatment following the diagnosis of localized prostate cancer.
Tawadros T., Valerio M., 2016. Expert Review of Anticancer Therapy, 16 (4) pp. 373-374. Peer-reviewed.
[DOI][Pmid][serval:BIB_F63BFDE5E128]
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.
De Visschere P.J., Briganti A., Fütterer J.J., Ghadjar P., Isbarn H., Massard C., Ost P., Sooriakumaran P., Surcel C.I., Valerio M. et al., 2016. Insights Into Imaging, 7 (2) pp. 205-214. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_323E63FC3C89]
 
The challenging landscape of medical device approval in localized prostate cancer.
Valerio M., Emberton M., Eggener S.E., Ahmed H.U., 2016. Nature Reviews. Urology, 13 (2) pp. 91-98. Peer-reviewed.
[DOI][Pmid][serval:BIB_1111499D5D73]
 
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping Biopsies.
Valerio M., Anele C., Bott S.R., Charman S.C., van der Meulen J., El-Mahallawi H., Emara A.M., Freeman A., Jameson C., Hindley R.G. et al., 2016. Journal of Urology, 195 (5) pp. 1403-1408. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49D93E3090FF]
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E17D73E719CC]
 
Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.
Valerio M., Anele C., Charman S.C., van der Meulen J., Freeman A., Jameson C., Singh P.B., Emberton M., Ahmed H.U., 2016. Bju International, 118 (3) pp. 384-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4973EEDBFA00]
2015
Cancer testiculaire: un modèle pour optimiser le suivi radiologique [Testicular cancer: a model to optimize the radiological follow-up].
Stebler V., Pauchard B., Schmidt S., Valerio M., De Bari B., Berthold D., 2015/05. Revue Médicale Suisse, 11 (475) pp. 1144-1148. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1E2A61B344CE]
 
A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer.
Willis S.R., van der Meulen J., Valerio M., Miners A., Ahmed H.U., Emberton M., 2015. Current Opinion In Urology, 25 (6) pp. 483-489. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F9DE99507C2]
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
[Pmid][serval:BIB_84B39813FF24]
 
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M., Donaldson I., Emberton M., Ehdaie B., Hadaschik B.A., Marks L.S., Mozer P., Rastinehad A.R., Ahmed H.U., 2015. European Urology, 68 (1) pp. 8-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_686C3618BA3C]
 
Dépistage du cancer de la prostate: partager avec le patient les incertitudes [Sharing uncertainties of prostate cancer screening].
Selby K., Auer R., Valerio M., Jichlinski P., Cornuz J., 2015. Revue Médicale Suisse, 11 (496) pp. 2216, 2218-2216, 2220.
[Pmid][serval:BIB_2E2F578888E0]
 
Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
Valerio M., Ahmed H.U., Emberton M., 2015. Techniques in Vascular and Interventional Radiology, 18 (3) pp. 147-152. Peer-reviewed.
[DOI][Pmid][serval:BIB_4829CA2C0D35]
 
Identifying the index lesion with template prostate mapping biopsies.
Valerio M., Anele C., Freeman A., Jameson C., Singh P.B., Hu Y., Emberton M., Ahmed H.U., 2015. Journal of Urology, 193 (4) pp. 1185-1190. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C17BA00B68EE]
 
Inégalité des sexes face au cancer en urologie [Gender disparities in urologic cancers].
Lucca I., Valerio M., Jichlinski P., Cerantola Y., 2015. Revue Médicale Suisse, 11 (497) pp. 2276-8, 2280.
[Pmid][serval:BIB_F61CE55212D3]
 
Methodological considerations in assessing the utility of imaging in early prostate cancer.
Valerio M., Willis S., van der Meulen J., Emberton M., Ahmed H.U., 2015. Current Opinion in Urology, 25 (6) pp. 536-542. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3A60C71A900]
 
MRI/TRUS fusion software-based targeted biopsy: the new standard of care?
Manfredi M., Costa Moretti T.B., Emberton M., Villers A., Valerio M., 2015. Minerva Urologica e Nefrologica, 67 (3) pp. 233-246. Peer-reviewed.
[WoS][Pmid][serval:BIB_039DA3FB7A5A]
 
Technological aspects of delivering cryotherapy for prostate cancer.
Lau B., Shah T.T., Valerio M., Hamid S., Ahmed H.U., Arya M., 2015. Expert Review of Medical Devices, 12 (2) pp. 183-190. Peer-reviewed.
[DOI][Pmid][serval:BIB_61DF062EFE13]
 
Urologie [Urology].
Boldini M., Cerantola Y., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (456-457) pp. 143-147.
[Pmid][serval:BIB_6B7F6BB57F82]
 
Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer.
Valerio M., McCartan N., Freeman A., Punwani S., Emberton M., Ahmed H.U., 2015. Urologic Oncology, 33 (10) pp. 424.e9-424.16.
[DOI][WoS][Pmid][serval:BIB_271EB9B3B077]
2014
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
Valerio M., Dickinson L., Ali A., Ramachandran N., Donaldson I., Freeman A., Ahmed H.U., Emberton M., 2014. Contemporary Clinical Trials, 39 (1) pp. 57-65.
[URN][DOI][WoS][Pmid][serval:BIB_EB1614BDCFCB]
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FAAFB52000CA]
 
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Valerio M., El-Shater Bosaily A., Emberton M., Ahmed H.U., 2014. Urologic Oncology, 32 (6) pp. 924-930. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD52F90960C9]
 
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Patel H.R., Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Müller S., Baldini G. et al., 2014. European Urology, 65 (2) pp. 263-266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A6A1760D9CF4]
Focal therapy will become a standard option for selected men with localized prostate cancer.
Valerio M., Emberton M., Ahmed H.U., 2014. Journal of Clinical Oncology, 32 (32) pp. 3680-3681. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CD7F9A7EC388]
 
Health technology assessment in evolution - focal therapy in localised prostate cancer.
Valerio M., Emberton M., Barret E., Eberli D., Eggener S.E., Ehdaie B., Jichlinski P., Ward J.F., Ahmed H.U., 2014. Expert Review of Anticancer Therapy, 14 (11) pp. 1359-1367. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C52345D9509B]
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.
Valerio M., Stricker P.D., Ahmed H.U., Dickinson L., Ponsky L., Shnier R., Allen C., Emberton M., 2014. Prostate Cancer and Prostatic Diseases, 17 (4) pp. 343-347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22E52AF9AAD1]
 
Prise en charge opératoire multimodale des calculs de la voie urinaire supérieure [Multimodal surgical management of stones in the upper urinary tract].
Fritschi Urs O.M., Kabongo O.M., Tawadros T., Jichlinski P., Valerio M., 2014. Revue Médicale Suisse, 10 (453) pp. 2316-8, 2320-1.
[Pmid][serval:BIB_863C3B1E945B]
 
Re: jarow et Al.: drug and device development for localized prostate cancer: report of a food and drug administration/american urological association public workshop (urology 2014;83:975-979).
Valerio M., Emberton M., Ahmed H.U., 2014. Urology, 84 (3) pp. 732-733.
[DOI][WoS][Pmid][serval:BIB_A25E60BAF207]
 
Re: tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?: f. Cornud, g. Khoury, N. Bouazza, f. Beuvon, m. Peyromaure, T. Flam, m. Zerbib, p. Legmann and N. B. Delongchamps j urol 2014; 191: 1272-1279.
Valerio M., Ahmed H.U., 2014. Journal of Urology, 192 (4) pp. 1297-1298.
[DOI][WoS][Pmid][serval:BIB_331E7FA54420]
The role of focal therapy in the management of localised prostate cancer: a systematic review.
Valerio M., Ahmed H.U., Emberton M., Lawrentschuk N., Lazzeri M., Montironi R., Nguyen P.L., Trachtenberg J., Polascik T.J., 2014. European Urology, 66 (4) pp. 732-751. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C0A1B52AB56C]
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
[Pmid][serval:BIB_E22C4882AE84]
2013
 
Are patients at nutritional risk more prone to complications after major urological surgery?
Cerantola Y., Valerio M., Hubner M., Iglesias K., Vaucher L., Jichlinski P., 2013. Journal of Urology, 190 (6) pp. 2126-2132. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE1935BCC10C]
 
Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?
Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P., 2013. Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada, 7 (11-12) pp. E699-E703. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D6CAE6A7B117]
 
Experimental evaluation of an electromechanical artificial urinary sphincter in an animal model.
Valerio M., Jichlinski P., Dahlem R., Tozzi P., Mundy A.R., 2013. BJU International, 112 (4) pp. E337-E343.
[DOI][WoS][Pmid][serval:BIB_240712615A76]
 
Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Muller S., Baldini G., Carli F. et al., 2013. Clinical Nutrition, 32 (6) pp. 879-887. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BF7B6988128]
2012
Percutaneous drainage and sclerotherapy as definitive treatment of renal lymphangiomatosis.
Valerio M., Meuwly J.Y., Tawadros C., Jichlinski P., 2012. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 6 (1) pp. E3-E7.
[URN][DOI][WoS][Pmid][serval:BIB_D4E2D0F25D67]
2011
Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman.
Valerio M., Lhermitte B., Bauer J., Jichlinski P., 2011. Rare Tumors, 3 (1) pp. e9.
[URN][DOI][Pmid][serval:BIB_403FF403101F]
 
Surveillance active du cancer de la prostate [Active surveillance in prostate cancer].
Valerio M., Vaucher L., Cerantola Y., Berthold D., Herrera F.G, Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2388-2391. Peer-reviewed.
[Pmid][serval:BIB_03B22396178D]
2010
 
R6le de l'urotlogue dans le dépistage des maladies osseuses [Role of the urologist in the screening of bone diseases].
Valerio M., Lamy O., Paduch D.A., Jichlinski P., Vaucher L., 2010. Revue Médicale Suisse, 6 (274) pp. 2340-2345.
[Pmid][serval:BIB_BE1646B41DF2]
2009
 
Prise en charge des coliques néphrétiques en urgence [Emergency management of renal colic]
Valerio M., Doerfler A., Chollet Y., Schreyer N., Guyot S., Jichlinski P., 2009/12. Revue Médicale Suisse, 5 (228) pp. 2457-2461.
[Pmid][serval:BIB_AAE9F61EB68D]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University